Got feedback on the new design? We're Listening! Send us Feedback

Genentech's Avastin Not Recommended for Breast Cancer (Update4) »

Posted by: KevinLucas 8 months, 2 weeks ago

0 Comments Report this Story

1.0

Scale of 1 to 10

Read: 4

Propped: 1

Comments: 0

Click Prop It to Raise Score
Prop it

Genentech Inc.'s Avastin, the drugmaker's second-biggest product, should be rejected for use against breast cancer, U.S. advisers said. Genentech fell the most in more than five years on the New York Stock Exchange before trading was halted.The panel of cancer drug experts advising the U.S. Food and Drug Administration voted 5-4 today that the drug

Read Full Story at worldtous.com

Join the Discussion

+ Add Comment
Comments So Far: 0

You must be signed in to post a comment. Sign in »

Submitted By:
KevinLucas

Also submitted:

Related Articles:

Why not submit a story?

Also Propping This Article

view all »

Groups Watching This

No groups are watching this story. Why not share it with your group?

Advertisement